NO3051026T3 - - Google Patents
Info
- Publication number
- NO3051026T3 NO3051026T3 NO16160669A NO16160669A NO3051026T3 NO 3051026 T3 NO3051026 T3 NO 3051026T3 NO 16160669 A NO16160669 A NO 16160669A NO 16160669 A NO16160669 A NO 16160669A NO 3051026 T3 NO3051026 T3 NO 3051026T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161550148P | 2011-10-21 | 2011-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO3051026T3 true NO3051026T3 (fr) | 2018-07-28 |
Family
ID=48136439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO16160669A NO3051026T3 (fr) | 2011-10-21 | 2009-04-01 |
Country Status (18)
| Country | Link |
|---|---|
| US (6) | US20150087525A1 (fr) |
| EP (2) | EP2944700B1 (fr) |
| JP (2) | JP6159727B2 (fr) |
| KR (2) | KR101912731B1 (fr) |
| CN (2) | CN104651521B (fr) |
| AU (1) | AU2012356317B2 (fr) |
| BR (2) | BR122015004941B1 (fr) |
| CA (1) | CA2852850C (fr) |
| DK (2) | DK2768986T3 (fr) |
| ES (2) | ES2688693T3 (fr) |
| HU (2) | HUE039522T2 (fr) |
| IN (1) | IN2015DN01855A (fr) |
| MX (2) | MX357550B (fr) |
| NO (1) | NO3051026T3 (fr) |
| PL (2) | PL2944700T3 (fr) |
| PT (2) | PT2944700T (fr) |
| RU (2) | RU2662975C1 (fr) |
| WO (1) | WO2013093635A2 (fr) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014513521A (ja) | 2011-01-26 | 2014-06-05 | セファイド | 肺癌を検出する方法 |
| US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| DK2893040T5 (en) | 2012-09-04 | 2019-03-18 | Guardant Health Inc | METHODS TO DETECT RARE MUTATIONS AND CAPITAL VARIATION |
| EP3378952B1 (fr) | 2013-12-28 | 2020-02-05 | Guardant Health, Inc. | Procédés et systèmes de détection de variants génétiques |
| US10260105B2 (en) | 2014-02-18 | 2019-04-16 | Baylor Research Institute | MiR-320e and colorectal cancer |
| US10604810B2 (en) | 2014-06-13 | 2020-03-31 | Toray Industries, Inc. | Colorectal cancer detection kit or device, and detection method |
| WO2016034715A2 (fr) * | 2014-09-05 | 2016-03-10 | Prestizia | Methode de prediction de l'evolution clinique du cancer colorectal |
| CN104313142B (zh) * | 2014-10-16 | 2016-02-03 | 上海交通大学医学院附属仁济医院 | miRNA-30a作为标记分子在制备诊断试剂中的用途 |
| CN104388541B (zh) * | 2014-10-21 | 2017-07-04 | 复旦大学附属肿瘤医院 | miR‑1914*和miR‑1915的用途 |
| CN104372004B (zh) * | 2014-12-04 | 2018-04-27 | 广东医学院 | 一个与心肌梗死易感相关的miR-27a基因单核苷酸多态位点的检测方法及其应用 |
| US12188092B2 (en) * | 2015-03-09 | 2025-01-07 | Agency For Science, Technology And Research | Method of determining the risk of developing breast cancer by detecting the expression levels of microRNAs (miRNAs) |
| EP3147370A1 (fr) * | 2015-09-28 | 2017-03-29 | Rheinische Friedrich-Wilhelms-Universität Bonn | Micro-arn exosomal dans du sérum comme indicateur pour l'activation de graisse marron et beige tissu adipeux (bat) |
| EP3390668A4 (fr) | 2015-12-17 | 2020-04-01 | Guardant Health, Inc. | Procédés de détermination du nombre de copies du gène tumoral par analyse d'adn acellulaire |
| CN110139936A (zh) * | 2016-08-18 | 2019-08-16 | N·特兰 | 口腔癌、咽癌和喉癌的生物标记 |
| EP3327135A1 (fr) * | 2016-11-28 | 2018-05-30 | Advanced Marker Discovery, S.L. | Procédé in vitro d'identification d'adénomes colorectaux ou du cancer colorectal |
| CN106950370A (zh) * | 2017-01-25 | 2017-07-14 | 上海市第十人民医院 | 血液微小核酸大肠癌诊断分子组合 |
| CN107254522A (zh) * | 2017-06-09 | 2017-10-17 | 中山大学附属第三医院 | miR‑664a‑5p的检测试剂在制备肝癌诊断试剂/试剂盒中的应用 |
| CN107236799B (zh) * | 2017-06-15 | 2020-06-09 | 昆明医科大学第六附属医院 | 一种肾纤维化miRNA标记物 |
| CN107326092B (zh) * | 2017-08-25 | 2021-07-20 | 深圳市恩普电子技术有限公司 | 大肠癌相关的miRNA作为生物标志物的应用及大肠癌检测试剂盒 |
| CN107746886B (zh) * | 2017-09-11 | 2019-10-01 | 朱伟 | 一种与结直肠癌辅助诊断相关的血浆miRNA标志物及其应用 |
| WO2019144183A1 (fr) * | 2018-01-23 | 2019-08-01 | La Trobe University | Biomarqueurs du cancer colorectal |
| EP3752645A4 (fr) | 2018-02-14 | 2022-04-13 | Dermtech, Inc. | Nouveaux classificateurs de gènes et leurs utilisations dans des cancers de la peau sans mélanome |
| CN110205367B (zh) * | 2018-02-28 | 2022-06-21 | 伽蓝（集团）股份有限公司 | 一种筛选保护皮肤细胞端粒的活性物的方法 |
| KR20210031640A (ko) * | 2018-05-09 | 2021-03-22 | 덤테크, 인크. | 신규한 유전자 분류자 및 자가면역 질환에서의 이의 용도 |
| CN114438214B (zh) * | 2018-06-27 | 2023-12-22 | 深圳华大生命科学研究院 | 结直肠癌肿瘤标志物及其检测方法与装置 |
| CN109557311B (zh) * | 2018-12-13 | 2022-02-15 | 中南大学湘雅医院 | 结直肠癌诊断标志物及结直肠癌的检测产品及其应用 |
| KR102275465B1 (ko) * | 2019-01-18 | 2021-07-09 | 사회복지법인 삼성생명공익재단 | 전이성 대장암 치료물질 스크리닝 방법 |
| WO2020182106A1 (fr) * | 2019-03-11 | 2020-09-17 | The Chinese University Of Hong Kong | Marqueurs de miarn pour le cancer colorectal |
| CN110438227A (zh) * | 2019-07-29 | 2019-11-12 | 广州中昱医学生物科技有限公司 | miR-17-92在结直肠癌诊断中的用途 |
| CN112080568A (zh) * | 2020-09-27 | 2020-12-15 | 扬州大学 | 一种与湖羊肌肉细胞增殖相关的miRNA标志物及其检测引物和应用 |
| JPWO2023032452A1 (fr) * | 2021-08-31 | 2023-03-09 | ||
| WO2023036266A1 (fr) * | 2021-09-08 | 2023-03-16 | Guangdong Jiyin Biotech Co. Ltd | Compositions et méthodes pour le diagnostic du cancer colorectal |
| CN113981096A (zh) * | 2021-11-30 | 2022-01-28 | 无锡市疾病预防控制中心 | 一种用于诊断结直肠癌的血浆miRNA标志物及其应用 |
| WO2023222927A2 (fr) | 2022-05-20 | 2023-11-23 | Novigenix Sa | Biomarqueurs pour la néoplasie colorectale |
| CN119144728A (zh) * | 2024-11-19 | 2024-12-17 | 四川大学华西医院 | 原发性肝癌的MicroRNA标志物的引物、试剂盒和应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| GB0415277D0 (en) * | 2004-07-07 | 2004-08-11 | Colonix Ltd | Apparatus and method for sampling mucosal surfaces |
| US7939255B2 (en) | 2006-07-03 | 2011-05-10 | Catholic University Industry Academy Cooperation Foundation | Diagnostic methods for colorectal cancer |
| WO2008055158A2 (fr) * | 2006-10-30 | 2008-05-08 | University Of South Alabama | Microarn en tant que biomarqueur dans le cancer |
| JP5501766B2 (ja) | 2006-11-01 | 2014-05-28 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 肝細胞癌における生存および転移を予測するためのマイクロｒｎａ発現サイン |
| KR20100093539A (ko) * | 2007-10-30 | 2010-08-25 | 베리덱스, 엘엘씨 | 대장암을 모니터링하는 방법 |
| CN101424640B (zh) * | 2007-11-02 | 2012-07-25 | 江苏命码生物科技有限公司 | 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法 |
| EP2268832A2 (fr) * | 2008-03-06 | 2011-01-05 | Asuragen, INC. | Marqueurs microrna pour la récurrence d un cancer colorectal |
| WO2009140670A2 (fr) * | 2008-05-16 | 2009-11-19 | Veridex, Llc | Procédé d'évaluation du cancer colorectal et compositions utilisables à cet effet |
| WO2010004562A2 (fr) | 2008-07-09 | 2010-01-14 | Rosetta Genomics Ltd. | Procédés et compositions permettant de détecter un cancer colorectal |
| GB2463401B (en) * | 2008-11-12 | 2014-01-29 | Caris Life Sciences Luxembourg Holdings S A R L | Characterizing prostate disorders by analysis of microvesicles |
| US9074206B2 (en) * | 2008-11-13 | 2015-07-07 | Fudan University | Compositions and methods for micro-RNA expression profiling of colorectal cancer |
| WO2010126355A1 (fr) * | 2009-04-29 | 2010-11-04 | Academisch Medisch Centrum Bij De Universiteit Van Amsterdam | Moyens et procédés pour contrecarrer, prévenir et/ou déterminer une insuffisance cardiaque ou un risque d'insuffisance cardiaque |
| US20100317533A1 (en) | 2009-06-05 | 2010-12-16 | British Columbia Cancer Agency Branch | Biomarkers of cancer metastasis |
| EP2336353A1 (fr) * | 2009-12-17 | 2011-06-22 | febit holding GmbH | Empreinte miARN dans le diagnostic des maladies |
| WO2011012136A1 (fr) | 2009-07-28 | 2011-02-03 | Exiqon A/S | Procédé de classification d'un échantillon de cellules humaines comme cancéreux |
| CN101988060A (zh) * | 2009-07-30 | 2011-03-23 | 江苏命码生物科技有限公司 | 结直肠癌检测标记物及其检测方法、试剂盒和生物芯片 |
| WO2011044541A2 (fr) * | 2009-10-09 | 2011-04-14 | Baylor Research Institute | Identification de microarn (miarn) dans des échantillons fécaux comme biomarqueurs des cancers de l'appareil digestif |
| WO2011076142A1 (fr) * | 2009-12-24 | 2011-06-30 | Fudan University | Compositions et procédés pour le profilage de l'expression de micro-arn dans un plasma d'un cancer colorectal |
| WO2011076147A1 (fr) | 2009-12-24 | 2011-06-30 | Fudan University | Biomarqueurs et méthodes à microarn plasmatiques utilisés pour la détection précoce du cancer colorectal |
| CA2787027A1 (fr) | 2010-01-13 | 2011-07-21 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Detection d'affections gastro-intestinales |
| TW201207395A (en) * | 2010-06-23 | 2012-02-16 | Univ Hong Kong Chinese | Micro-RNA markers for colorectal cancer |
-
2009
- 2009-04-01 NO NO16160669A patent/NO3051026T3/no unknown
-
2012
- 2012-10-20 DK DK12852462.6T patent/DK2768986T3/en active
- 2012-10-20 CA CA2852850A patent/CA2852850C/fr active Active
- 2012-10-20 ES ES12852462.6T patent/ES2688693T3/es active Active
- 2012-10-20 MX MX2014004810A patent/MX357550B/es active IP Right Grant
- 2012-10-20 PT PT151581857T patent/PT2944700T/pt unknown
- 2012-10-20 HU HUE12852462A patent/HUE039522T2/hu unknown
- 2012-10-20 DK DK15158185.7T patent/DK2944700T3/en active
- 2012-10-20 KR KR1020157005756A patent/KR101912731B1/ko active Active
- 2012-10-20 CN CN201510098369.5A patent/CN104651521B/zh active Active
- 2012-10-20 RU RU2015108970A patent/RU2662975C1/ru active
- 2012-10-20 EP EP15158185.7A patent/EP2944700B1/fr active Active
- 2012-10-20 MX MX2015002910A patent/MX357119B/es unknown
- 2012-10-20 BR BR122015004941-5A patent/BR122015004941B1/pt active IP Right Grant
- 2012-10-20 US US14/352,462 patent/US20150087525A1/en not_active Abandoned
- 2012-10-20 EP EP12852462.6A patent/EP2768986B1/fr active Active
- 2012-10-20 US US13/656,690 patent/US20130102487A1/en not_active Abandoned
- 2012-10-20 PL PL15158185T patent/PL2944700T3/pl unknown
- 2012-10-20 AU AU2012356317A patent/AU2012356317B2/en active Active
- 2012-10-20 ES ES15158185.7T patent/ES2662401T3/es active Active
- 2012-10-20 BR BR112014009643-0A patent/BR112014009643B1/pt active IP Right Grant
- 2012-10-20 JP JP2014536355A patent/JP6159727B2/ja active Active
- 2012-10-20 IN IN1855DEN2015 patent/IN2015DN01855A/en unknown
- 2012-10-20 WO PCT/IB2012/003035 patent/WO2013093635A2/fr active Application Filing
- 2012-10-20 KR KR1020147013663A patent/KR101900872B1/ko active Active
- 2012-10-20 CN CN201280064096.7A patent/CN104145024A/zh active Pending
- 2012-10-20 PT PT12852462T patent/PT2768986T/pt unknown
- 2012-10-20 RU RU2014120427A patent/RU2611189C2/ru active
- 2012-10-20 HU HUE15158185A patent/HUE035614T2/en unknown
- 2012-10-20 PL PL12852462T patent/PL2768986T3/pl unknown
-
2015
- 2015-03-05 JP JP2015043433A patent/JP6203209B2/ja active Active
- 2015-03-05 US US14/639,539 patent/US20150176082A1/en not_active Abandoned
-
2016
- 2016-06-14 US US15/181,578 patent/US20160289771A1/en not_active Abandoned
-
2018
- 2018-06-28 US US16/022,597 patent/US20180346996A1/en active Pending
- 2018-08-08 US US16/058,940 patent/US20180355439A1/en active Pending